Mass General Cancer Center's Dr. Kerry Reynolds, Director of the Severe Immunotherapy Complications Program, and Dr. Chloe Villani, Director of the Single Cell Genomics Program, are a package deal. Billy Costa of Kiss 108 Radio sits down with both of them to learn about the incredible team dynamic between research and clinical practice for patients at Mass General Cancer Center.
Mass General Cancer Center's Dr. Kerry Reynolds and Dr. Chloe Villani are a package deal. Billy Costa of Kiss 108 Radio sits down with both of them to learn about the incredible team dynamic between research and clinical practice for patients at Mass General Cancer Center.
The Severe Immunotherapy Complications Service at Mass General was created to address the urgent need to understand how and why toxicities occur, in order to develop new therapies that will allow patients to safely stay on their lifesaving immunotherapy regimens.
